Ledger.Open graph →
SEC Form D · filed December 22, 2025

Addition Therapeutics, Inc

Offering
$28.0M
Sold
$28.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Peter Bisgaard · San Jose, CADirectorKathleen Collins · South San Francisco, CADirectorJayson Punwani · Calabasas, CADirectorMatthew Patterson · Dover, DEDirectorLawrence Kong · South San Francisco, CAExecJennifer Lee · Princeton, NJDirectorLaetitia Schwab · South San Francisco, CADirectorRonald Park · South San Francisco, CAExec · DirectorKathleen Collins · South San Francisco, CADirectorJayson Punwani · Calabasas, CADirectorMatthew Patterson · Dover, DEDirectorPeter Bisgaard · Bagsvaerd, NetherlandsDirectorLawrence Kong · South San Francisco, CAExecJennifer Lee · Princeton, NJDirectorLaetitia Schwab · South San Francisco, CADirectorRonald Park · South San Francisco, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗